Authors: Fujimiya, Y Suzuki, Y Katakura, R Ohno, T

Citation: Y. Fujimiya et al., Injury to autologous normal tissues and tumors mediated by lymphokine-activated killer (LAK) cells generated in vitro from peripheral blood mononuclear cells of glioblastoma patients, J HEMATOTH, 8(1), 1999, pp. 29-37

Authors: Suzuki, Y Fujimiya, Y Ohno, T Katakura, R Yoshimoto, T

Citation: Y. Suzuki et al., Enhancing effect of tumor necrosis factor (TNF)-alpha, but not IFN-gamma, on the tumor-specific cytotoxicity of gamma delta T cells from glioblastomapatients, CANCER LETT, 140(1-2), 1999, pp. 161-167

Authors: Fujimiya, Y Suzuki, Y Katakura, R Ebina, T

Citation: Y. Fujimiya et al., Tumor-specific cytocidal and immunopotentiating effects of relatively low molecular weight products derived from the basidiomycete, Agaricus blazei Murill, ANTICANC R, 19(1A), 1999, pp. 113-118

Authors: Ebina, T Fujimiya, Y Yamaguchi, T Ogama, N Sasaki, H Isono, N Suzuki, Y Katakura, R Tanaka, K Nagata, K Takano, S Tamura, K Uno, K Kishida, T

Citation: T. Ebina et al., The use of BRM-activated killer cells in adoptive immunotherapy: A pilot study with nine advanced cancer patients, BIOTHERAPY, 11(4), 1998, pp. 241-253